/
Pharmaceutical preparations company · DE · FY ends Dec · Revenue $205M · -47.15% margin · -$98M FCF
The business is unprofitable at the operating level (-91.36% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 216.9% YoY with margins expanding 410.8pp.
Negative free cash flow of -$167M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$205M
▲ +216.9% YoY
Net Income (TTM)
-$157M
▲ +33.8% YoY
Op. Margin
-47.15%
▲ +410.8pp YoY
ROIC
-38.45%
Cash Flow & Balance Sheet
FCF (TTM)
-$98M
▲ +37.4% YoY
Op. Cash Flow (TTM)
-$97M
▲ +37.5% YoY
Net Debt
-$15M
Net Cash Position
Cash & Equiv.
$181M
Continue Research